SEC alleges insider trading ahead of CNOOC-Nexen deal

New Post Public Reply Private Reply Replies (0) Message Board
MaxShockeR

SEC alleges insider trading ahead of CNOOC-Nexen deal

July 28 2012 WASHINGTON (Reuters) - The U.S. securities regulator filed a complaint in court on Friday against a firm controlled by a Chinese billionaire and other traders, accusing them of making over $13 million from insider trading ahead of a bid by China's CNOOC for Canadian oil company Nexen Inc.

The Securities and Exchange Commission said the federal court in Manhattan had frozen assets worth over $38 million belonging to Hong Kong-based Well Advantage, controlled by businessman Zhang Zhirong, and other unnamed traders who used accounts in Hong Kong and Singapore to trade in Nexen stock.

They made trading profits of $7 million and $6 million respectively by using inside knowledge of the merger to buy Nexen shares before the announcement, the SEC says.

The trading was suspicious, the SEC claims in its complaint, because the accounts used to buy the shares had 'either no history or extremely limited history" of buying Nexen shares before July 2012.

CNOOC said on July 23 it had agreed to acquire Nexen for $15.1 billion, China's biggest foreign takeover bid. Shares of Nexen jumped almost 52 percent that day.

The unnamed Singapore traders used accounts in the names of Phillip Securities and Citibank, while Well Advantage made its trades through accounts held at UBS Securities and Citigroup Global Markets. Neither of the Well Advantage accounts had traded Nexen shares since January 2012, and the Citigroup account had been completely dormant for over six months.

Zhang Zhirong also controls China Rongsheng Heavy Industries Group Holdings, which according to a company filing in October 2010, entered a strategic cooperation agreement with CNOOC.

A spokeswoman for CNOOC declined to comment. Calls to Well Advantage's office in Hong Kong were not answered on Saturday.

Hong Kong's Securities and Futures Commission also declined comment while officials at the Monetary Authority of Singapore were not immediately available.

The SEC does not allege any wrongdoing by Zhang, but notes that he is the controlling shareholder of a company that engages in significant business activities with CNOOC.

Zhang was ranked the 22th richest Chinese person by Forbes Magazine in September 2011. But his net worth fell by more than half in the past year to $2.6 billion in March 2012 as shares of Rongsheng tumbled. The stock ended at HK$1.4 on Friday against an IPO price of HK$8.0 fixed in November 2010.

Well-timed bullish bets in Nexen options ahead of the announcement also raised eyebrows among some market watchers on the day the deal was announced.

"Well Advantage and these other traders engaged in an all-too-familiar pattern of misusing inside information to place extremely timely trades and profit handsomely from their illegal acts," said Sanjay Wadhwa, deputy chief of the market abuse unit in the SEC's enforcement division.

In addition to freezing the traders' assets and directing them not to destroy any evidence, the SEC is seeking a judgment "ordering the traders to disgorge their ill-gotten gains with interest, pay financial penalties, and permanently bar them from future violations," according to a statement.

The SEC is cracking down on insider trading, it says, having brought 57 insider trading actions in the financial year 2011 against 124 individuals and entities, a nearly 8 percent increase in the number of filed actions from the prior fiscal year.

Wadhwa acknowledged in his statement "the challenges of investigating misconduct in the U.S. by trading accounts located overseas," and the SEC will have to work with regulators in Hong Kong and Singapore where the alleged insider trading took place.

(Reporting by Aruna Viswanatha, additional reporting by Lawrence White, Kelvin Soh and Alison Leung in HONG KONG; Rachel Armstrong in SINGAPORE; editing by Raju Gopalakrishnan)

http://finance.yahoo.com/news/sec-alleges-ins...33542.html


Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 175

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 428

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 0

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 105

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading

Top 5 Most Recently Viewed Articles

Sands China Earns S&P Global ESG Top 1% Honors Again

Updated Category News Views 6

Breaking Down Sands China's Sustainability Triumph In the business realm, nabbing top spots in ESG is no walk in the park. Yet here’s Sands China, storming into 2026 with its fourth consecutive Top 1% spot in S&P Global’s Sustainability Yearbook for China and a hat-trick running for the global edition. That’s a fancy accolade in a space where sustainability ain't...

Continue Reading
Trailblazer Merger Corp I Raises Borrowing Limit for Growth

Updated Category News Views 56

Trailblazer Merger Corp I Enhances Financial Strength Trailblazer Merger Corporation I (NASDAQ:TBMC), a well-known special purpose acquisition company, has taken substantial steps to boost its financial capabilities. The company recently modified its borrowing agreement, which includes an increase in its credit line and an extension of the loan’s maturity date, as...

Continue Reading
Year-Round Joy: Transforming Lives with Toys for Tots

Updated Category News Views 128

Spreading Joy All Year Long with Marine Toys for Tots Why limit the spirit of giving to just one season? Marine Toys for Tots actively cultivates a culture of joy and generosity, ensuring that the joy of the holiday season extends far beyond December. As America's leading charity for children during the holidays, their mission resonates deeply throughout the year,...

Continue Reading
Unearthing History: The Remarkable Bronze Age Town in Arabia

Updated Category News Views 124

Unearthing the Significant Bronze Age Town The landscape of northwest Arabia has just revealed a stunning archaeological gem: an ancient Bronze Age town that challenges conventional notions about the region's historical trajectory. This remarkable discovery, made in the Khaybar oasis, brings insights into the transition from nomadic lifestyles to structured town living, a...

Continue Reading
Discover Perlick's Innovative Beverage Centers and Wine Columns

Updated Category News Views 199

Perlick’s New Column Beverage Centers and Wine Columns Perlick is introducing a fresh take on how you store and show off what you drink: all-new column beverage centers and wine columns built to raise the everyday experience. The company’s roots go back to 1917, and that century-plus of know?how shows up here—thoughtful engineering, clean design, and durable...

Continue Reading